Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer.
about
Current Chemotherapy and Potential New Targets in Uterine LeiomyosarcomaOligonucleotide Therapies: The Past and the PresentTargeting MYC Dependence by Metabolic Inhibitors in CancerTools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks.Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.The past and presence of gene targeting: from chemicals and DNA via proteins to RNA.
P2860
Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@en
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@nl
type
label
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@en
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@nl
prefLabel
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@en
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@nl
P2093
P2860
P356
P1476
Triplex-forming oligonucleotid ...... a mouse model of human cancer.
@en
P2093
Howard Thames
Karen M Vasquez
Laura A Christensen
Lezlee Coghlan
Rick A Finch
Stephen B Boulware
P2860
P304
P356
10.1002/MC.22026
P577
2013-05-16T00:00:00Z